|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 131 - 140 of 441:
FDA Panel Recommends Approval of SyntheMed's REPEL-CV Adhesion Barrier for Pediatric Patients
SyntheMed, a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products, announced today that t...
FDA Approves Nasal Influenza Vaccine for Use in Younger Children
The U.S. Food and Drug Administration (FDA) today sent a warning letter to Procter & Gamble for making unlawful claims about its Vicks Early Defense F...
FDA Clears for Marketing First Rapid Test to Screen for Bacterial Contamination in Blood Platelets
The U.S. Food and Drug Administration has cleared for marketing the first rapid test to detect bacterial contamination in blood platelets prior to tra...
Increased Regulatory Scrutiny Spurs Pharmaceutical Companies to Restructure Medical Publications Departments
A new study released by Cutting Edge Information finds that many pharmaceutical companies are revamping their medical publication structures in respon...
8 Out Of 10 Compliance Managers Believe That Too Much “Noise” Is Threatening Management Attitudes To Compliance And Risk:Survey
An “overkill” emphasis on compliance and risk avoidance is testing operational management attitudes. A survey to establish current thinking on Gove...
Lanmark Group Expands its Regulatory Compliance Capabilities
Lanmark Group, a full-service, business-to-business, advertising, marketing, and communications agency specializing in brand empowerment for the healt...
McAfee Redefines Security and Compliance Management
McAfee announced availability of McAfee ePolicy Orchestrator 4.0 (ePO), the first and only platform that lets enterprises and governments, centrally m...
Nanosphere Announces First FDA Cleared Genetic Test for Warfarin Sensitivity and Nanotechnology-based Molecular Diagnostics Platform
Nanosphere, nanotechnology-based molecular diagnostics company, announced that it has received clearance from the U.S. Food and Drug Administration (F...
St. Jude Medical Announces FDA Approval of Company’s First Radiofrequency Wireless ICD and CRT-D Heart Failure Devices
-St. Jude Medical, announced U.S. Food and Drug Administration (FDA) approval of its first radiofrequency (RF) wireless devices to treat patients with...
AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |